Autopsy report · NCT03456700

Auranofin and Sirolimus in Treating Participants With Ovarian Cancer

“The study is closed per results from the interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 22 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Ovarian Serous Tumor; Recurrent Ovarian Carcinoma

Interventions

Auranofin; Laboratory Biomarker Analysis; Sirolimus

Participants

22

Sites

1

Countries

United States

Trials that died the same way

• A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
  “This study was terminated after a pre-specified interim analysis. Please see Detailed Study Description for further information.” (76% match in meaning)
• A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
  “Interim analysis results from the open-label part of the study. The double blind portion of the study will be resumed once the study will continue.” (75% match in meaning)
• Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT
  “We obtained the final results due to the interim analysis.” (73% match in meaning)
• A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
  “Study was stopped following interim analysis.” (73% match in meaning)
• Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections
  “The study was terminated early after the Interim Analysis due, in part, to issues with the accuracy and completeness of the data collected.” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.